CIK 0001541157 · Non-accelerated filer<br>Smaller reporting company
Akari Therapeutics Plc
Sign in to watch- Ticker
- AKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- EIN
- 981034922
- Phone
- (929) 274-7510
- Business address
- 401 EAST JACKSON STREET, SUITE 3300, TAMPA, FL, 33602
- Former names
- Celsus Therapeutics Plc., Morria Biopharmaceuticals PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-27 | Gaslightwala Abizer Director | Grant or award | +40,000,000 | $0.00 | $20K | 70,000,000 |
| 2024-12-26 | Patel Samir Rashmikant Director | Grant or award | +3,200,000 | $0.00 | $2K | 5,248,903,500 |
| 2024-12-26 | Gaslightwala Abizer Director | Grant or award | +30,000,000 | $0.00 | $15K | 30,000,000 |
| 2024-12-24 | Patel Samir Rashmikant Director | Grant or award | +7,500,000 | $0.00 | $4K | 5,245,703,500 |
| 2024-12-23 | Neal James R Director | Grant or award | +2,000,000 | $0.00 | $1K | 24,216,000 |
| 2024-12-23 | Patel Samir Rashmikant Director | Grant or award | +1,400,000 | $0.00 | $700 | 5,238,203,500 |
| 2024-12-20 | Patel Samir Rashmikant Director | Grant or award | +1,400,000 | $0.00 | $700 | 5,236,803,500 |
| 2024-12-02 | Patel Samir Rashmikant Director | Grant or award | +419,286,000 | $0.00 | $503K | 5,235,403,500 |
| 2024-12-02 | Patel Samir Rashmikant Director | Grant or award · Warrants (Right to Buy) | +419,286,000 | $0.00 | $503K | 419,286,000 |
| 2024-12-02 | Prudo-Chlebosz Raymond Director | Grant or award | +419,286,000 | $0.00 | $503K | 4,077,124,600 |
| 2024-12-02 | Prudo-Chlebosz Raymond Director | Grant or award · Warrants (Right to Buy) | +419,286,000 | $0.00 | $503K | 419,286,000 |
| 2024-11-30 | Patel Samir Rashmikant Director | Grant or award · Stock Option (Right to Buy) | +162,604,000 | 162,604,000 | ||
| 2024-11-14 | Patel Samir Rashmikant Director | Grant or award | +1,404,622,000 | 4,816,117,500 | ||
| 2024-10-31 | Patel Samir Rashmikant Director | Grant or award · Stock Option (Right to Buy) | +79,684,000 | 79,684,000 | ||
| 2024-09-30 | Patel Samir Rashmikant Director | Grant or award · Stock Option (Right to Buy) | +175,080,000 | 175,080,000 | ||
| 2024-09-17 | Bazemore Robert B Director | Grant or award · Stock Option (Right to Buy) | +5,000,000 | 5,000,000 | ||
| 2024-06-30 | Patel Samir Rashmikant Director | Grant or award | +91,396,000 | 91,396,000 | ||
| 2024-06-28 | WILLIAMS DONALD A Director | Grant or award · Stock Option (Right to Buy) | +5,000,000 | 5,000,000 | ||
| 2024-06-28 | Hashad Mohamed Wa'el Ahmed Director | Grant or award · Stock Option (Right to Buy) | +5,000,000 | 5,000,000 | ||
| 2024-06-28 | Prudo-Chlebosz Raymond Director | Grant or award · Stock Option (Right to Buy) | +10,000,000 | 10,000,000 |
Page 8 of 11 · 216 trades